Abstract
A spectrum of cognitive impairments known as HIV-associated neurocognitive disorders (HAND) are consequences of the effects of HIV-1 within the central nervous system. Regardless of treatment status, an aberrant chronic neuro-immune regulation is a crucial contributor to the development of HAND. However, the extent to which inflammation affects brain structures critical for cognitive status remains unclear. The present study aimed to determine associations of peripheral immune markers with cortical thickness and surface area. Participants included 65 treatment-naïve HIV-positive individuals and 26 HIV-negative controls. Thickness and surface area of all cortical regions were derived using automated parcellation of T1-weighted images acquired at 3 T. Peripheral immune markers included C-C motif ligand 2 (CCL2), matrix metalloproteinase 9 (MMP9), neutrophil gelatinase-associated lipocalin (NGAL), thymidine phosphorylase (TYMP), transforming growth factor (TGF)-β1, and vascular endothelial growth factor (VEGF), which were measured using enzyme-linked immunosorbent assays. Associations of these markers with thickness and surface area of cortical regions were evaluated. A mediation analysis examined whether associations of inflammatory markers with cognitive functioning were mediated by brain cortical thickness and surface area. After controlling for multiple comparisons, higher NGAL was associated with reduced thickness of the bilateral orbitofrontal cortex in HIV-positive participants. The association of NGAL with worse motor function was mediated by cortical thickness of the bilateral orbitofrontal region. Taken together, this study suggests that NGAL plays a potential role in the neuropathophysiology of neurocognitive impairments of HIV.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Acevedo A, Loewenstein DA, Barker WW et al (2000) Category fluency test: normative data for English- and Spanish-speaking elderly. J Int Neuropsychol Soc 6:760–769
Ances BM, Ortega M, Vaida F, Heaps J, Paul R (2012) Independent effects of HIV, aging, and HAART on brain volumetric measures. J Acquir Immune Defic Syndr 59:469–477. https://doi.org/10.1097/QAI.0b013e318249db17
Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S, Singer EJ, Wolinsky SM, Gabuzda D (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3:10–20. https://doi.org/10.1371/journal.pone.0002516
Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG, Ferrara N, Sofroniew MV, John GR (2012) Astrocyte-derived VEGF-A drives blood–brain barrier disruption in CNS inflammatory disease. J Clin Invest 122:2454–2468. https://doi.org/10.1172/JCI60842
Aylward EH, Henderer JD, Mcarthur JC et al (1993) Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 43:2099–2104
Barr TL, Latour LL, Lee K-Y, Schaewe TJ, Luby M, Chang GS, el-Zammar Z, Alam S, Hallenbeck JM, Kidwell CS, Warach S (2010) Blood–brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. Stroke 41:e123–e128. https://doi.org/10.1161/STROKEAHA.109.570515
Benedict RHB, Schretlen D, Groninger L, Brandt J (1998) Hopkins verbal learning test? Revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol (Neuropsychology, Dev Cogn sect D) 12:43–55. https://doi.org/10.1076/clin.12.1.43.1726
Bi F, Huang C, Tong J, Qiu G, Huang B, Wu Q, Li F, Xu Z, Bowser R, Xia XG, Zhou H (2013) Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci U S A 110:4069–4074. https://doi.org/10.1073/pnas.1218497110
Boven LA, Gomes L, Hery C, et al (1999) Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J Immunol 162:4319–27
Campbell GR, Watkins JD, Singh KK, Loret EP, Spector SA (2007) Human immunodeficiency virus type 1 subtype C tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J Virol 81:5919–5928. https://doi.org/10.1128/JVI.01938-06
Capuron L, Miller AH (2011) Immune system to brain signaling: Neuropsychopharmacological implications. Pharmacol Ther 130:226–238
Cardenas V, Meyerhoff D, Studholme C, Kornak J, Rothlind J, Lampiris H, Neuhaus J, Grant RM, Chao LL, Truran D, Weiner MW (2009) Evidence for ongoing brain injury in human immunodeficiency viruspositive patients treated with antiretroviral therapy. J Neuro-Oncol 15:324–333. https://doi.org/10.1080/13550280902973960
Chakraborty S, Kaur S, Guha S, Batra SK (2012) The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta – Rev Cancer 1826:129–169
Chapouly C, Tadesse Argaw A, Horng S, Castro K, Zhang J, Asp L, Loo H, Laitman BM, Mariani JN, Straus Farber R, Zaslavsky E, Nudelman G, Raine CS, John GR (2015) Astrocytic TYMP and VEGFA drive blood–brain barrier opening in inflammatory central nervous system lesions. Brain 138:1548–1567. https://doi.org/10.1093/brain/awv077
Clifford DB, Ances BM (2013) HIV-associated neurocognitive disorder. Lancet Infect Dis 13:6–86. https://doi.org/10.1016/S1473-3099(13)70269-X
Cohen RA, de la Monte S, Gongvatana A, Ombao H, Gonzalez B, Devlin KN, Navia B, Tashima KT (2011) Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning. J Neuroimmunol 233:204–210. https://doi.org/10.1016/j.jneuroim.2010.11.006
Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B (2010) Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J Neuro-Oncol 16:25–32. https://doi.org/10.3109/13550280903552420
Corlier F, Hafzalla G, Faskowitz J, Kuller LH, Becker JT, Lopez OL, Thompson PM, Braskie MN (2018) Systemic inflammation as a predictor of brain aging: contributions of physical activity, metabolic risk, and genetic risk. Neuroimage. 172:118–129. https://doi.org/10.1016/j.neuroimage.2017.12.027
Correia S, Cohen R, Gongvatana A, Ross S, Olchowski J, Devlin K, Tashima K, Navia B, Delamonte S (2013) Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV. J Neuroimmunol 265:117–123. https://doi.org/10.1016/j.jneuroim.2013.09.005
D’Elia L, Satz P, Uchiyama C, White T (1996) Color trails test: professional manual. L: Psychological Assessment Resources, Odessa
De Oliveira MF, Murrel B, Pérez-Santiago J et al (2015) Circulating HIV DNA correlates with neurocognitive impairment in older HIV-infected adults on suppressive ART. Sci Rep 5:17094. https://doi.org/10.1038/srep17094
Dekens DW, Naudé PJW, Engelborghs S et al (2017) Neutrophil gelatinase-associated lipocalin and its receptors in Alzheimer’s disease (AD) brain regions: differential findings in AD with and without depression. J Alzheimers Dis. https://doi.org/10.3233/JAD-160330
Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968–980. https://doi.org/10.1016/j.neuroimage.2006.01.021
Dhar A, Gardner J, Borgmann K, Wu L, Ghorpade A (2006) Novel role of TGF-β in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammation. J Neurosci Res 83:1271–1280. https://doi.org/10.1002/jnr.20787
Du J, Rolls ET, Cheng W et al (2020) Functional connectivity of the orbitofrontal cortex, anterior cingulate cortex, and inferior frontal gyrus in humans. Cortex. 123:185–199. https://doi.org/10.1016/j.cortex.2019.10.012
Eugenin EA (2006) CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood–brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 26:1098–1106. https://doi.org/10.1523/JNEUROSCI.3863-05.2006
Falasca K, Reale M, Ucciferri C, di Nicola M, di Martino G, D'Angelo C, Coladonato S, Vecchiet J (2017) Cytokines, hepatic fibrosis, and antiretroviral therapy role in neurocognitive disorders HIV related. AIDS Res Hum Retrovir 33:246–253. https://doi.org/10.1089/aid.2016.0138
Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341–355. https://doi.org/10.1016/S0896-6273(02)00569-X
Gandhi N, Saiyed Z, Thangavel S, Rodriguez J, Rao KVK, Nair MPN (2009) Differential effects of HIV type 1 clade B and clade C tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes. AIDS Res Hum Retrovir 25:691–699. https://doi.org/10.1089/aid.2008.0299
Golden CJ (1975) A group version of the Stroop color and word test. J Pers Assess 39:386–388. https://doi.org/10.1207/s15327752jpa3904_10
Gongvatana A, Correia S, Dunsiger S, Gauthier L, Devlin KN, Ross S, Navia B, Tashima KT, DeLaMonte S, Cohen RA (2014) Plasma cytokine levels are related to brain volumes in HIV-infected individuals. J NeuroImmune Pharmacol 9:740–750. https://doi.org/10.1007/s11481-014-9567-8
Guha D, Wagner MCE, Ayyavoo V (2018) Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury. J Neuroinflammation 15:126. https://doi.org/10.1186/s12974-018-1160-2
Hayes AF (2009) Beyond Baron and Kenny: statistical mediation analysis in the new millennium. Commun Monogr 76:408–420. https://doi.org/10.1080/03637750903310360
Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, For the CHARTER Group (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: charter study. Neurology 75:2087–2096. https://doi.org/10.1212/WNL.0b013e318200d727
Hogstrom LJ, Westlye LT, Walhovd KB, Fjell AM (2013) The structure of the cerebral cortex across adult life: age-related patterns of surface area, thickness, and gyrification. Cereb Cortex 23:2521–2530. https://doi.org/10.1093/cercor/bhs231
Imp BM, Rubin LH, Tien PC, Plankey MW, Golub ET, French AL, Valcour VG (2017) Monocyte activation is associated with worse cognitive performance in HIV-infected women with virologic suppression. J Infect Dis 215:114–121. https://doi.org/10.1093/infdis/jiw506
Jacomb I, Stanton C, Vasudevan R, Powell H, O'Donnell M, Lenroot R, Bruggemann J, Balzan R, Galletly C, Liu D, Weickert CS, Weickert TW (2018) C-reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls. Front Immunol 9. https://doi.org/10.3389/fimmu.2018.02230
Janssen MAM, Meulenbroek O, Steens SCA, Góraj B, Bosch M, Koopmans PP, Kessels RPC (2015) Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy. Aids 29:2139–2148. https://doi.org/10.1097/QAD.0000000000000824
Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KGF, Combrinck M, Paul RH, Stein DJ, Flisher AJ (2011) Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav 15:1197–1203. https://doi.org/10.1007/s10461-010-9744-6
Kallianpur KJ, Jahanshad N, Sailasuta N, Benjapornpong K, Chan P, Pothisri M, Dumrongpisutikul N, Laws E, Ndhlovu LC, Clifford KM, Paul RV, on behalf of the SSG (2019) Regional brain volumetric changes despite two years of treatment initiated during acute HIV infection. Aids. 43:E673–E682. https://doi.org/10.1097/BRS.0000000000002494
Kallianpur KJ, Kirk GR, Sailasuta N, Valcour V, Shiramizu B, Nakamoto BK, Shikuma C (2012) Regional cortical thinning associated with detectable levels of HIV DNA. Cereb Cortex 22:2065–2075. https://doi.org/10.1093/cercor/bhr285
Kallianpur KJ, Shikuma C, Kirk GR, Shiramizu B, Valcour V, Chow D, Souza S, Nakamoto B, Sailasuta N (2013) Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter. Neurology 80:1792–1799. https://doi.org/10.1212/WNL.0b013e318291903f
Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D (2012) Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. J Acquir Immune Defic Syndr 60:234–243. https://doi.org/10.1097/QAI.0b013e318256f3bc
Kamkwalala AR, Wang X, Maki PM, Williams DW, Valcour VG, Damron A, Tien PC, Weber KM, Cohen MH, Sundermann EE, Meyer VJ, Little DM, Xu Y, Rubin LH (2020) Higher peripheral monocyte activation markers are associated with smaller frontal and temporal cortical volumes in women with HIV. JAIDS J Acquir Immune Defic Syndr 84:54–59. https://doi.org/10.1097/qai.0000000000002283
Kaur SS, Gonzales MM, Eagan DE, Goudarzi K, Tanaka H, Haley AP (2015) Inflammation as a mediator of the relationship between cortical thickness and metabolic syndrome. Brain Imaging Behav 9:737–743. https://doi.org/10.1007/s11682-014-9330-z
Keating SM, Dodge JL, Norris PJ, Heitman J, Gange SJ, French AL, Glesby MJ, Edlin BR, Latham PS, Villacres MC, Greenblatt RM, Peters MG, the Women’s Interagency HIV Study (2017) The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury—the Women’s Interagency HIV Study. PLoS One 12:e0181004. https://doi.org/10.1371/journal.pone.0181004
Kellogg SH, McHugh PF, Bell K, Schluger JH, Schluger RP, LaForge K, Ho A, Kreek MJ (2003) The Kreek–McHugh–Schluger–Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend 69:137–150. https://doi.org/10.1016/S0376-8716(02)00308-3
Klove H (1963) Clinical neuropsychology. Med Clin North Am 47:1647–1658
Krebs SJ, Slike BM, Sithinamsuwan P, Allen IE, Chalermchai T, Tipsuk S, Phanuphak N, Jagodzinski L, Kim JH, Ananworanich J, Marovich MA, Valcour VG, SEARCH 011 study team (2016) Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals. AIDS 30:1533–1542. https://doi.org/10.1097/QAD.0000000000001096
Kumar GSS, Venugopal AK, Kashyap MK et al (2012) Gene expression profiling of tuberculous meningitis co-infected with HIV. J Proteomics Bioinform 05:235–244. https://doi.org/10.4172/jpb.1000243
Lee S, Lee J, Kim S, Park JY, Lee WH, Mori K, Kim SH, Kim IK, Suk K (2007) A dual role of Lipocalin 2 in the apoptosis and deramification of activated microglia. J Immunol 179:3231–3241. https://doi.org/10.4049/jimmunol.179.5.3231
Lee S, Park JY, Lee WH, Kim H, Park HC, Mori K, Suk K (2009) Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J Neurosci 29:234–249. https://doi.org/10.1523/JNEUROSCI.5273-08.2009
Mathad JS, Gupte N, Balagopal A, Asmuth D, Hakim J, Santos B, Riviere C, Hosseinipour M, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Mwelase N, Pawar J, Berendes S, Kumarasamy N, Andrade BB, Campbell TB, Currier JS, Cohn SE, Gupta A, New Work Concept Sheet 319 and AIDS Clinical Trials Group A5175 (PEARLS) Study Teams (2016) Sex-related differences in inflammatory and immune activation markers before and after combined antiretroviral therapy initiation. J Acquir Immune Defic Syndr 73:123–129. https://doi.org/10.1097/QAI.0000000000001095
Maung R, Hoefer MM, Sanchez AB, Sejbuk NE, Medders KE, Desai MK, Catalan IC, Dowling CC, de Rozieres CM, Garden GA, Russo R, Roberts AJ, Williams R, Kaul M (2014) CCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120. J Immunol 193:1895–1910. https://doi.org/10.4049/jimmunol.1302915
McCarrey AC, Pacheco J, Carlson OD, Egan J, Thambisetty M, An Y, Ferrucci L, Resnick S (2014) Interleukin-6 is linked to longitudinal rates of cortical thinning in aging. Transl Neurosci 5:1–7. https://doi.org/10.2478/S13380-014-0203-0
Meyerhoff DJ (2001) Effects of alcohol and HIV infection on the central nervous system. Alcohol Res Heal 25:288–298
Morris VL, Owens MM, Syan SK et al (2019) Associations between drinking and cortical thickness in younger adult drinkers: findings from the Human Connectome Project. Alcohol Clin Exp Res. https://doi.org/10.1111/acer.14147
Nag S, Eskandarian MR, Davis J, Eubanks JH (2002) Differential expression of vascular endothelial growth factor-a (VEGF-A) and VEGF-B after brain injury. J Neuropathol Exp Neurol 61:778–788
Naudé PJW, Nyakas C, Eiden LE et al (2012) Lipocalin 2: novel component of proinflammatory signaling in Alzheimer’s disease. FASEB J 26:2811–2823. https://doi.org/10.1096/fj.11-202457
Navia BA, Jordan BD, Price RW (1986) The AIDS dementia complex: I. Clinical features. Ann Neurol 19:517–524. https://doi.org/10.1002/ana.410190602
Netto TM, Greca DV, Ferracini R, Pereira DB, Bizzo B, Doring T, Kubo T, Bahia PRV, Fonseca RP, Gasparetto EL (2011) Correlation between frontal cortical thickness and executive functions performance in patients with human immunodeficiency virus infection. Radiol Bras 44:7–12. https://doi.org/10.1590/S0100-39842011000100006
O’Connor EE, Zeffiro TA, Zeffiro TA (2018) Brain structural changes following HIV infection: meta-analysis. Am J Neuroradiol 39:54–62. https://doi.org/10.3174/ajnr.A5432
Ortega M, Heaps JM, Joska J, Vaida F, Seedat S, Stein DJ, Paul R, Ances BM (2013) HIV clades B and C are associated with reduced brain volumetrics. J Neuro-Oncol 19:479–487. https://doi.org/10.1007/s13365-013-0202-x
Paul R (2019) Neurocognitive phenotyping of HIV in the era of antiretroviral therapy. Curr HIV/AIDS Rep 16:230–235
Perrella O, Carreiri PB, Perrella A, Sbreglia C, Gorga F, Guarnaccia D, Tarantino G (2001) Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): possible relationship with cerebral viral load? Eur Cytokine Netw 12:51–55
Ragin AB, Wu Y, Ochs R, Scheidegger R, Cohen BA, Edelman RR, Epstein LG, McArthur J (2010a) Biomarkers of neurological status in HIV infection: a 3-year study. Proteomics Clin Appl 4:295–303. https://doi.org/10.1002/prca.200900083
Ragin AB, Wu Y, Ochs R, Scheidegger R, Cohen BA, Edelman RR, Epstein LG, McArthur J (2010b) Biomarkers of neurological status in HIV infection: a 3-year study. Proteomics Clin Appl 4:295–303. https://doi.org/10.1002/prca.200900083
Rakic P (1988) Specification of cerebral cortical areas. Science (80- ). https://doi.org/10.1126/science.3291116
Ruiz AP, Ajasin DO, Ramasamy S et al (2019) A naturally occurring polymorphism in the HIV-1 tat basic domain inhibits uptake by bystander cells and leads to reduced neuroinflammation. Sci Rep 9. https://doi.org/10.1038/s41598-019-39531-5
Sacktor N (2018) Changing clinical phenotypes of HIV-associated neurocognitive disorders. J Neuro-Oncol
Sacktor N, Robertson K (2014) Evolving clinical phenotypes in HIV-associated neurocognitive disorders. Curr Opin HIV AIDS 9:517–520
Sanford R, Cruz ALF, Scott SC, et al (2017) Regionally specific brain volumetric and cortical thickness changes in HIV-infected patients in the HAART era. In: Journal of Acquired Immune Deficiency Syndromes. pp 563–570
Santerre M, Wang Y, Arjona S, Allen C, Sawaya BE (2019) Differential contribution of HIV-1 subtypes B and C to neurological disorders: mechanisms and possible treatments. AIDS Rev 21:76–83. https://doi.org/10.24875/aidsrev.19000051
Shapshak P, Duncan R, Minagar A et al (2004) Elevated expression of IFN-gamma in the HIV-1 infected brain. Front Biosci 9:1073–1081. https://doi.org/10.2741/1271
Sheehan DV, Lecrubier Y, Sheehan KH, et al (1998) The Mini-international Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. In: Journal of Clinical Psychiatry. pp 22–33
Sporer B, Koedel U, Paul R, Eberle J, Arendt G, Pfister HW (2004) Vascular endothelial growth factor (VEGF) is increased in serum, but not in cerebrospinal fluid in HIV associated CNS diseases. J Neurol Neurosurg Psychiatry 75:298–300
Tavazzi E, Morrison D, Sullivan P, Morgello S, Fischer T (2014) Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection. Curr HIV Res 12:97–110. https://doi.org/10.2174/1570162x12666140526114956
Thompson PM, Dutton RA, Hayashi KM, Toga AW, Lopez OL, Aizenstein HJ, Becker JT (2005) Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci 102:15647–15652. https://doi.org/10.1073/pnas.0502548102
Tyor W, Fritz-French C, Nath A (2013) Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders. J Neurovirol19:515–522
Van Essen DC (1997) A tension-based theory of morphogenesis and compact wiring in the central nervous system. Nature 385:313–318
Williams ME, Ipser JC, Stein DJ, Joska JA, Naudé PJW (2019) The association of immune markers with cognitive performance in South African HIV-positive patients. J NeuroImmune Pharmacol 14:679–687. https://doi.org/10.1007/s11481-019-09870-1
Williams ME, Ipser JC, Stein DJ, Joska JA, Naudé PJW (2020) Peripheral immune dysregulation in the ART era of HIV-associated neurocognitive impairments: a systematic review. Psychoneuroendocrinology 118:104689. https://doi.org/10.1016/j.psyneuen.2020.104689
Wong JK, Campbell GR, Spector SA (2010) Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C tat proteins. J Biol Chem 285:18319–18325. https://doi.org/10.1074/jbc.M110.120840
Woods SP, Morgan EE, Marquie-Beck J, Carey CL, Grant I, Letendre SL, HIV Neurobehavioral Research Center (HNRC) Group (2006) Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease. Cogn Behav Neurol 19:217–221. https://doi.org/10.1097/01.wnn.0000213916.10514.57
Wu JQ, Sassé TR, Saksena MM, Saksena NK (2013) Transcriptome analysis of primary monocytes from HIV-positive patients with differential responses to antiretroviral therapy. Virol J 10:361. https://doi.org/10.1186/1743-422X-10-361
Xing Y, Shepherd N, Lan J, Li W, Rane S, Gupta SK, Zhang S, Dong J, Yu Q (2017) MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders. Brain Behav Immun 65:161–172. https://doi.org/10.1016/j.bbi.2017.04.024
Acknowledgments
M.W. was funded by the National Research Foundation (NRF) (SFH180512328474) and Poliomyelitis Research Foundation (PRF) (16/91). P.N. was funded by the Harry Crossley Foundation and South African Society for Biological Psychiatry. D.J.S. was funded by the SAMRC.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Williams, M.E., Joska, J.A., Amod, A.R. et al. The association of peripheral immune markers with brain cortical thickness and surface area in South African people living with HIV. J. Neurovirol. 26, 908–919 (2020). https://doi.org/10.1007/s13365-020-00873-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-020-00873-w